LJUIF Stock Latest News
Company AnnouncementsSSY Group Wins China Approval for Nemonoxacin Bulk Drug3d ago
Company AnnouncementsSSY Group Boosts Employee Share Pool With Market Purchase Under Award Scheme4d ago
Company AnnouncementsSSY Group posts double-digit profit and revenue growth on IV solutions rebound6d ago
Company AnnouncementsSSY Group Wins China Bulk Drug Approval for Labetalol, Strengthening Hypertension Portfolio1w ago
Company AnnouncementsSSY Group Wins PRC Approval for New Preservative-Free Allergy Eye Drops2w ago
Company AnnouncementsSSY Group Wins China Approval for Nimodipine Oral Solution, Expands Neurology Portfolio3w agoCompany AnnouncementsSSY Group Revamps Board as Veteran Executive Wu Hengyao Joins, Su Xuejun Steps Down1M ago
- Company AnnouncementsSSY Group Wins China Approval for New Antipsychotic Bulk Drug1M ago
Company AnnouncementsSSY Group Wins China Approval for New Letermovir Injection1M ago
Company AnnouncementsSSY Group Buys 1 Million Shares for Employee Award Scheme1M ago
Company AnnouncementsSSY Group Boosts Staff Incentive Pool With Open-Market Share Purchase2M ago
Company AnnouncementsSSY Group Wins Key Approval for Diltiazem Cardiovascular Portfolio in China2M agoCompany AnnouncementsSSY Group Boosts Restricted Share Pool With Market Buyback for Incentive Scheme2M ago
Company AnnouncementsSSY Group Wins China Approvals for Two Key Diagnostic Injectables2M ago- Company AnnouncementsSSY Group Delivers Profit Growth and Higher Dividend Amid Sector Reforms2M ago
Company AnnouncementsSSY Group Declares Interim Cash Dividend for First Half of 20262M ago- Company AnnouncementsSSY Group Secures Approval for New Ozagrel Injection to Bolster Neurology Portfolio2M ago
Company AnnouncementsSSY Group Wins China Approval for Vitamin K1 Injection2M agoCompany AnnouncementsSSY Group Sets Board Meeting to Approve Interim Results and Consider Dividend2M ago
